[1] Hwang JH, Kim DW, Kim KS, et al. Mucosa-associated lymphoid tissue lymphoma of the accessory parotid gland presenting as a simple cheek mass: A case report[J].Medicine (Baltimore), 2019, 98(36):e17042. [2] Zhang T, Wu Y, Ju H, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients[J].Cancer Med, 2020, 9(1):194-203. [3] Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjögren syndrome[J].Nat Rev Rheumatol, 2018, 14(3):133-145. [4] Wotherspoon AC, Dogan A, Du MQ. Mucosa-associated lymphoid tissue lymphoma[J].Curr Opin Hematol, 2002, 9(1):50-55. [5] Dong L, Chen Y, Masaki Y, et al. Possible mechanisms of lymphoma development in Sjögren's syndrome[J].Curr Immunol Rev, 2013, 9(1):13-22. [6] Papageorgiou A, Ziogas DC, Mavragani CP, et al. Predicting the outcome of Sjögren's syndrome-associated non-hodgkin's lymphoma patients[J].PLoS One, 2015, 10(2):e0116189. [7] Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren's syndrome[J].Autoimmun Rev, 2004, 3(3):175-182. [8] Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases[J].Clin Exp Immunol, 2009, 158(2):155-163. [9] Szodoray P, Jellestad S, Teague MO, et al. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome[J].Lab Invest, 2003, 83(3):357-365. [10] Su Q, Yu GY. Research progress of salivary glands mucosa-associated lymphoid tissue lymphoma[J].Zhonghua Kou Qiang Yi Xue Za Zhi, 2018, 53(1):54-59. [11] Isaacson PG. Mucosa-associated lymphoid tissue lymphoma[J].Semin Hematol, 1999, 36(2):139-147. [12] Bacon CM, Du MQ, Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists[J].J Clin Pathol, 2007, 60(4):361-372. |